What are cancer patients willing to pay for prophylactic epoetin alfa? - A cost-benefit analysis (multiple letters)

B. Orhan; S. Yalcin; G. Dranitsaris

doi:10.1002/(SICI)1097-0142(19990915)86:6<1095::AID-CNCR28>3.0.CO;2-K

What are cancer patients willing to pay for prophylactic epoetin alfa? - A cost-benefit analysis (multiple letters)

B. Orhan
, S. Yalcin
, G. Dranitsaris

Uludag University

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	1095-1096
Number of pages	2
Journal	Cancer
Volume	86
Issue number	6
DOIs	https://doi.org/10.1002/(SICI)1097-0142(19990915)86:6<1095::AID-CNCR28>3.0.CO;2-K
Publication status	Published - 15 Sept 1999
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1002/(SICI)1097-0142(19990915)86:6<1095::AID-CNCR28>3.0.CO;2-K

Cite this

@article{dabc178086534b598fa16dcbac5f9c2b,

title = "What are cancer patients willing to pay for prophylactic epoetin alfa? - A cost-benefit analysis (multiple letters)",

author = "B. Orhan and S. Yalcin and G. Dranitsaris",

year = "1999",

month = sep,

day = "15",

doi = "10.1002/(SICI)1097-0142(19990915)86:6<1095::AID-CNCR28>3.0.CO;2-K",

language = "English",

volume = "86",

pages = "1095--1096",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc",

number = "6",

}

TY - JOUR

T1 - What are cancer patients willing to pay for prophylactic epoetin alfa? - A cost-benefit analysis (multiple letters)

AU - Orhan, B.

AU - Yalcin, S.

AU - Dranitsaris, G.

PY - 1999/9/15

Y1 - 1999/9/15

UR - https://www.scopus.com/pages/publications/0033568682

U2 - 10.1002/(SICI)1097-0142(19990915)86:6<1095::AID-CNCR28>3.0.CO;2-K

DO - 10.1002/(SICI)1097-0142(19990915)86:6<1095::AID-CNCR28>3.0.CO;2-K

M3 - Letter

C2 - 10491539

AN - SCOPUS:0033568682

SN - 0008-543X

VL - 86

SP - 1095

EP - 1096

JO - Cancer

JF - Cancer

IS - 6

ER -

What are cancer patients willing to pay for prophylactic epoetin alfa? - A cost-benefit analysis (multiple letters)

UN SDGs

Access to Document

Other files and links

Cite this